17-66216941-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_000042.3(APOH):​c.631C>T​(p.Pro211Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000138 in 1,450,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

APOH
NM_000042.3 missense

Scores

5
7
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.92

Publications

0 publications found
Variant links:
Genes affected
APOH (HGNC:616): (apolipoprotein H) Apolipoprotein H, also known as beta-2-glycoprotein I, is a component of circulating plasma lipoproteins. It has been implicated in a variety of physiologic pathways including lipoprotein metabolism, coagulation, hemostasis, and the production of antiphospholipid autoantibodies. APOH may be a required cofactor for anionic phospholipid binding by the antiphospholipid autoantibodies found in sera of many patients with lupus and primary antiphospholipid syndrome (APS). The anti-beta (2) glycoprotein I antibodies from APS patients, mediate inhibition of activated protein C which has anticoagulant properties. Because beta-2-GPI is the main autoantigen in patients with APS, the disruption of this pathway by autoantibodies may be an important mechanism for thrombosis in patients with APS.[provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.767

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOHNM_000042.3 linkc.631C>T p.Pro211Ser missense_variant Exon 6 of 8 ENST00000205948.11 NP_000033.2 P02749A0A384NKM6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOHENST00000205948.11 linkc.631C>T p.Pro211Ser missense_variant Exon 6 of 8 1 NM_000042.3 ENSP00000205948.6 P02749
APOHENST00000581797.5 linkc.451C>T p.Pro151Ser missense_variant Exon 6 of 6 3 ENSP00000463553.1 J3QLI0
APOHENST00000585162.1 linkc.103C>T p.Pro35Ser missense_variant Exon 2 of 3 2 ENSP00000462260.1 J3KS17

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1450010
Hom.:
0
Cov.:
30
AF XY:
0.00000277
AC XY:
2
AN XY:
721024
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32826
American (AMR)
AF:
0.00
AC:
0
AN:
41864
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25686
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39364
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83596
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107682
Other (OTH)
AF:
0.00
AC:
0
AN:
59956
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 27, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.631C>T (p.P211S) alteration is located in exon 6 (coding exon 6) of the APOH gene. This alteration results from a C to T substitution at nucleotide position 631, causing the proline (P) at amino acid position 211 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Uncertain
25
DANN
Benign
0.93
DEOGEN2
Benign
0.39
T;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.81
T;T
M_CAP
Benign
0.030
D
MetaRNN
Pathogenic
0.77
D;D
MetaSVM
Uncertain
0.14
D
MutationAssessor
Uncertain
2.8
M;.
PhyloP100
4.9
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.4
D;.
REVEL
Uncertain
0.41
Sift
Benign
0.32
T;.
Sift4G
Benign
0.52
T;.
Polyphen
0.94
P;.
Vest4
0.52
MutPred
0.62
Gain of sheet (P = 0.0827);.;
MVP
0.77
MPC
0.63
ClinPred
0.99
D
GERP RS
5.9
Varity_R
0.60
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr17-64213059; API